Representatives from Kenvue China attend the launch event for Xisimin Cetirizine Hydrochloride Tablets in Shanghai on July 4, 2026. [Photo provided to chinadaily.com.cn]
With rising health awareness and growing pressure on medical resources driving demand for reliable self-care products and services, Kenvue Inc, the United States-based consumer health company, will expand its focus on minor ailment management in China as the country steps up efforts to improve public health literacy and advance universal health coverage.
Speaking ahead of International Self-Care Day on Friday, Gift Arpaporn Samabhandhu, president of Kenvue China, said China offers enormous market potential as consumers place greater emphasis on self-care and preventive health.
The New Jersey-headquartered group, whose brands include Rhinocort, Motilium, Daktarin, Motrin, and Listerine, operates across categories such as allergy relief, digestive health, pediatric care, oral health, and fungal infection treatments.
"Minor ailments are common and closely linked to people's daily lives, but many consumers still lack the confidence or knowledge to manage them properly," Samabhandhu said.
